TIL Therapy: A New Melanoma Treatment 30 Years in the Making
The journey to the first approved TIL therapy began with Steven A. Rosenberg over 30 years ago.
The journey to the first approved TIL therapy began with Steven A. Rosenberg over 30 years ago.
The FDA issued 14 oncology approvals this quarter, including the first tumor-infiltrating lymphocyte therapy.
“The field of cell therapy is one of the most exciting fields in translational medicine,” began Katayoun Rezvani, MD, PhD,...